The firm plans to release a research-use-only version of its test by the end of the year, and is still hoping for FDA clearance in 2019.
Sensitivity problems with rapid antigen tests are also helping the more accurate rapid molecular tests gain wider acceptance, manufacturers said.
Anitoa's handheld Maverick platform weighs one kilogram and comes with cloud-based analysis software.
The company said it would use the funding to continue development of its human microbiome research kits, protocols, and software.
OpGen recently launched the first Acuitas test, which is designed to detect the most common bacterial causes of complicated urinary tract infections.
Researchers from Rockefeller University sifted through soil microbiomes for genes linked to the function of calcium-dependent antibiotics.
The company has also developed two liquid biopsy cancer test, Liquid GPS Core for DNA and Liquid GPS Expression for RNA.
During the quarter, the company reopened its CLIA lab in New Haven, Connecticut, following the company's merger with Transgenomic in June.
The Sentosa SA201 HSV-1/2 PCR test detects herpes virus DNA from oral or anal skin lesions in symptomatic patients.
Launch Diagnostics will distribute BioGx's entire product line, including laboratory-use-only products, in the UK and Ireland.
The molecular test can provide results in 30 minutes from nasal swabs on a palm-sized instrument.
Designed to run on the company's Sentosa real-time PCR system, the test has been approved for identifying and differentiating Zika in patients.
The PCR-based methylation assay is intended to help predict the response of certain high-risk breast cancer patients to anthracycline-based chemotherapy.
The proposed diagnostic platform will be able to identify and determine resistance of bloodstream infections within three hours.
The company recently demonstrated the potential of its PCR and NGS assays to diagnose infections in patients' prosthetic knees and hips.
The PCR-based cartridge is designed to detect 21 pneumonia pathogens and 19 genetic markers of antibiotic resistance, and runs on the company's Unyvero system.
The firm saw revenue growth across all segments, with diagnostic systems revenues increasing 14 percent.
AxonLab will distribute BioGx's entire product line, including laboratory-use-only products, in central European countries.
Qiagen believes the flexibility of the Stat-Dx platform for an evolving reimbursement landscape will set it apart from other similar commercial platforms.
The products are used to monitor the chimeric status of stem cell or bone marrow transplant recipients.
Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.
King's College London researchers examine the influence of school type and genetics on academic achievement.
FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.
In Science this week: early life experience influence somatic variation in the genome, and more.